首页> 外文会议>Southern Biomedical Engineering Conference >Influence of heparin, heparin plus aprotinin and hirudin on contact activation in a cardiopulmonary bypass model
【24h】

Influence of heparin, heparin plus aprotinin and hirudin on contact activation in a cardiopulmonary bypass model

机译:肝素,肝素加抑肽酶和血红素在心肺旁路模型中接触激活的影响

获取原文

摘要

In the present study the authors used an in vitro cardiopulmonary bypass model to compare activation of the FXII-plasma kallikrein systems, coagulation pathway and blood cell changes, with heparin (3 U/ml), heparin plus aprotinin (3 U/ml and 250 KIU/ml) and recombinant hirudin (6 /spl mu/g/ml). After 90 minutes circulation the results showed that with heparin plus aprotinin and with hirudin the activation of these cascade reactions was markedly lower. In particular kallikrein-like activities and PMN-Elastase-/spl alpha//sub 1/-PI levels were significantly lower in the latter two groups. The least activation was detected with hirudin. The authors' results confirm that the contact systems of blood are activated during CPB with heparin as anticoagulant that aprotinin reduces this activation and that recombinant hirudin would be preferred to heparin as an anticoagulant in cardiac surgery.
机译:在本研究中,作者使用了体外心肺旁路模型来比较FXII-血浆Kallikrein系统的活化,凝血途径和血细胞变化,肝素(3u / ml),肝素加上抑肽酶(3u / ml和250 Kiu / ml)和重组均鲁蛋白(6 / SPL mu / g / ml)。 90分钟后,循环后,结果表明,肝素加上抑肽蛋白和随着血红素的激活,这些级联反应的激活显着降低。特别是Kallikrein的活性和PMN-Elastase- / SPLα//亚胚胎1 / -PI水平在后两组中显着降低。用HIRUDIN检测到最少的激活。作者的结果证实,在CPB期间用肝素激活血液的接触系统,作为抗凝血剂,即抑肽蛋白减少了这种激活,并且重组的血红素将优选肝素作为心脏手术的抗凝血剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号